Medicine & Life Sciences
Positron-Emission Tomography
100%
Amyloid
51%
Brain
40%
2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole
37%
Nicotinic Receptors
36%
3-(1,4-diazabicyclo(3.2.2)nonan-4-yl)-6-fluorodibenzo(b,d)thiophene 5,5-dioxide
27%
Alzheimer Disease
25%
4-cyano-1-(2,4-dichlorophenyl)-5-(4-methoxyphenyl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide
21%
18F-fluorobenzyl triphenyl phosphonium
20%
N-(N-((S)-1,3-Dicarboxypropyl)carbamoyl)-4-(18F)fluorobenzyl-L-cysteine
20%
Papio
18%
Molecular Imaging
17%
Neuroimaging
17%
altanserin
17%
Ligands
15%
Prostate-Specific Antigen
15%
Amyloid Plaques
14%
4-Aminobenzoic Acid
13%
Cognitive Dysfunction
13%
Injections
13%
Rifampin
12%
Kinetics
11%
Quality Control
11%
thioflavin T
10%
benzothiazole
10%
Epoxide Hydrolases
10%
Radioactivity
10%
2-(6-fluoro-2,3'-bipyridin-5'-yl)-7-methyl-7-azabicyclo(2.2.1)heptane
9%
Pharmacokinetics
9%
Cannabinoid Receptor CB1
9%
Metabotropic Glutamate 5 Receptor
9%
Membranes
8%
Transgenic Mice
8%
Radiometry
8%
Pyrogens
8%
Electrons
8%
Serotonin
8%
Epinephrine
8%
Meningeal Tuberculosis
8%
7-azabicyclo(2.2.1)heptane
7%
Schizophrenia
7%
2-(6-methyl-3,6-diazabicyclo(3.2.0)heptan-3-yl)-7-(6-methyl-3,6-diazabicyclo(3.2.0)heptan-3-yl)-9H-fluoren-9-one
7%
Catecholamines
7%
Carbon-11
7%
Prostatic Neoplasms
7%
Cannabinoid Receptors
7%
5-(6-(5-methylhexahydropyrrolo(3,4-c)pyrrol-2(1H)-yl)pyridazin-3-yl)-1H-indole
7%
Receptor, Serotonin, 5-HT1A
7%
Corpus Striatum
7%
6-O-(2-(18F)fluoroethyl)-6-O-desmethyldiprenorphine
7%
Chemical Compounds
Positron
48%
Radiochemical Yield
19%
Acetylcholine
16%
Radioligand
15%
Quality Control
9%
Clearance
9%
Kd
9%
Radioactivity
9%
Cannabinoid
7%
Beta-Amyloid
6%
Ligand
6%
Heptane
6%
Lipophilicity
5%
Antagonist
5%
3-O-Methyl-D-Glucose
5%